← TrialMatch
HomeTrials

Psychoeducational Course for Suicide Prevention

The plan is to include patients with a history of increased risk of suicide. In the aftermath of an episode of imminent suicide risk, patients will receive a psychoeducational course that entails information on different aspects of suicide-related topics, identifying triggers and detecting early warning signals for inc

Condition(s)Suicide Prevention, Suicide Threat, Self Efficacy, Stress, Psychological, Psychiatric Emergency, Psychiatric Disorder
StatusRecruiting
PhaseNA
Study typeInterventional
SummaryThe plan is to include patients with a history of increased risk of suicide. In the aftermath of an episode of imminent suicide risk, patients will receive a psychoeducational course that entails information on different aspects of suicide-related topics, identifying triggers and detecting early warning signals for increased suicide risk. The course culminates in working on completing a individual safety plan to prevent an future increase in suicide risk. The course will incorporate both patients and their next of kin. The psychoeducational course will be compared to a control group where the patients receive one individual session with focus on a safety plan to evaluate the intervention. Both groups will receive treatment as usual (TAU) during both the acute phase and follow-up. The study
Who can participateInclusion Criteria: * Patients with a suicide attempt, suicidal behavior, or risk of suicidal behavior and a clinician evaluating that the patient has an intention to die * Patients with a suicide attempt or suicidal behavior defined as "a self-inflicted, potentially injurious behavior with a non-fatal outcome for which there is evidence of intention of death and/or considered to have had or been close to a suicidal crisis syndrome. Exclusion Criteria: * Not being sufficiently fluent in Norwegian to provide informed consent, valid responses on psychometric testing or to benefit from a psychoeducative course. * A known diagnosis of ICD-10 F 60.3 (borderline personality disorder) with similar symptoms at previous admittances. * Ongoing psychosis. * A substance abuse condition to such a degre
Ages18 Years to 99 Years
SexAll
Lead sponsorSt. Olavs Hospital
LocationsLevanger, Trøndelag, Norway; Trondheim, Trøndelag, Norway
Start date2024-06-03
NCT IDNCT06466356
Official listinghttps://clinicaltrials.gov/study/NCT06466356

🔍 Search all trials →